Network origin in Tero Piispanen first degree
Entity | Entity type | Industry | |
---|---|---|---|
Innomedica Oy
Innomedica Oy Miscellaneous Commercial ServicesCommercial Services Innomedica is an international business consulting company serving the biotechnology and pharmaceutical industries. It provides a range of professional business development and project management services to its clients in both the public and private sectors. Innomedica's service portfolio includes Business Development, Licensing & Partnering, Japan Markets and Project Management. It is active on a global basis, though it specializes in the North European and Japanese markets. Its people are its main asset. Its success is based on leveraging the experience of professionals from different disciplines to deliver value to its clients. Its team portrays backgrounds from experienced business people to skilled lawyers and biomedical scientists. Innomedica was founded in 1997, and is a privately held company. Its client base covers both private and public sectors, both large and small.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tero Piispanen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Turku | College/University | Doctorate Degree | |
University of Helsinki | College/University | Graduate Degree | |
Debiopharm Innovation Fund /Management/
Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Investment Managers | Chief Executive Officer | |
Kaiku Health Oy
Kaiku Health Oy Information Technology ServicesTechnology Services Kaiku Health Oy engages in the provision of digital health interventions for cancer patients. It offers patient-reported outcome monitoring and intelligent system tracking. The company was founded by Kaarlo Haikonen, Joel Lehikoinen, Henri Virtanen, Otto Seiskari and Lauri Sippola in 2012 and is headquartered in Helsinki, Finland. | Information Technology Services | Chairman | |
Immunexpress, Inc.
Immunexpress, Inc. Miscellaneous Commercial ServicesCommercial Services Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in | Miscellaneous Commercial Services | Director/Board Member | |
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France. | Information Technology Services | Director/Board Member | |
Iktos SAS
Iktos SAS Packaged SoftwareTechnology Services Iktos SAS is a French company that specializes in generative modeling for drug discovery. The company is based in Paris, France and was founded in 2016 by Nicolas Do Huu, Yann Gaston-Mathé, and Quentin Perron. The company's offerings include professional services, research collaborations, partnerships, and software and SaaS licenses. The company's innovative technology platform includes generative modeling solutions with built-in synthetic accessibility. Contact them at contact@iktos.com for more details. Yann Gaston-Mathé has been the CEO since 2016. | Packaged Software | Director/Board Member |
Statistics
International
Finland | 4 |
France | 3 |
Switzerland | 2 |
Canada | 2 |
United States | 2 |
Sectoral
Technology Services | 4 |
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Commercial Services | 2 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Chairman | 2 |
Doctorate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Tanja Dowe | 8 |
Hannu Sundqvist | 2 |
Solveig Sjöblom | 1 |
- Stock Market
- Insiders
- Tero Piispanen
- Company connections